| Secondary |
| Product Used For Unknown Indication |
54.8% |
| Drug Use For Unknown Indication |
11.1% |
| Helicobacter Infection |
8.9% |
| Diabetes Mellitus |
5.2% |
| Pain |
3.7% |
| Colonoscopy |
2.2% |
| Juvenile Arthritis |
2.2% |
| Alveolitis |
1.5% |
| Multiple Myeloma |
1.5% |
| Rheumatoid Arthritis |
1.5% |
| Abdominal Pain Upper |
0.7% |
| Arthralgia |
0.7% |
| Atrial Fibrillation |
0.7% |
| Barrett's Oesophagus |
0.7% |
| Blood Pressure Management |
0.7% |
| Epilepsy |
0.7% |
| Gastric Disorder |
0.7% |
| Glomerulonephritis Chronic |
0.7% |
| Hyperlipidaemia |
0.7% |
| Hypertension |
0.7% |
|
| Hepatitis |
9.4% |
| Melaena |
9.4% |
| Mucous Stools |
9.4% |
| Renal Failure Acute |
9.4% |
| Blood Creatinine Increased |
6.3% |
| Drug Interaction |
6.3% |
| Nausea |
6.3% |
| Rhabdomyolysis |
6.3% |
| Bezoar |
3.1% |
| Drug Hypersensitivity |
3.1% |
| Enterobacter Sepsis |
3.1% |
| Epilepsy |
3.1% |
| Hallucination |
3.1% |
| Hypomagnesaemia |
3.1% |
| Hypophosphataemia |
3.1% |
| Ischaemic Stroke |
3.1% |
| Large Intestine Perforation |
3.1% |
| Listeria Sepsis |
3.1% |
| Magnesium Deficiency |
3.1% |
| Neutropenia |
3.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
20.1% |
| Drug Use For Unknown Indication |
8.6% |
| Contraception |
7.2% |
| Multiple Myeloma |
7.1% |
| Pain |
6.2% |
| Gastrooesophageal Reflux Disease |
5.1% |
| Amyloidosis |
5.0% |
| Atrial Fibrillation |
5.0% |
| Hypertension |
5.0% |
| Rheumatoid Arthritis |
4.0% |
| Breast Cancer |
3.7% |
| Prophylaxis |
3.7% |
| Acne |
3.6% |
| Cerebrovascular Accident Prophylaxis |
3.3% |
| Adenocarcinoma Pancreas |
2.8% |
| Depression |
2.1% |
| Acute Myocardial Infarction |
1.9% |
| Cardiac Failure Chronic |
1.9% |
| Anxiety |
1.8% |
| Chronic Obstructive Pulmonary Disease |
1.8% |
|
| Vomiting |
16.2% |
| Toxicity To Various Agents |
8.8% |
| Weight Decreased |
8.1% |
| Cardiac Tamponade |
6.6% |
| Wound Drainage |
6.6% |
| Dyspnoea |
5.1% |
| Pulmonary Embolism |
5.1% |
| Anaemia |
4.4% |
| Abdominal Pain |
3.7% |
| Pancreatitis |
3.7% |
| Postmenopause |
3.7% |
| Renal Failure Acute |
3.7% |
| Vanishing Bile Duct Syndrome |
3.7% |
| Cytolytic Hepatitis |
2.9% |
| Dyspepsia |
2.9% |
| Gastrointestinal Haemorrhage |
2.9% |
| Haematemesis |
2.9% |
| Portal Vein Thrombosis |
2.9% |
| Rash |
2.9% |
| Renal Impairment |
2.9% |
|
| Interacting |
| Product Used For Unknown Indication |
50.0% |
| Prophylaxis |
50.0% |
|
|
